Bradley L. Campbell, President and CEO: Amicus Therapeutics FOLD Sell · Filed 25/12/17

Trade details

Type: Insider sale
Amount: $846,276.36
Shares · price: 77,926 sh · $10.86 a share
Held after: 1,129,782 sh
Stock: Amicus Therapeutics FOLD
Person: Bradley L. CampbellPresident and CEO
Trade date: 25/12/15
Filed: 25/12/17
Days to filing: 2 days

Sold 6.5% of holdings

Share of holding sold: 6.5%

Amicus Therapeutics trades, last 26 weeks

What else happened in Amicus Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/15~01/14

Bradley L. Campbell's recent trades

Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$322.9K
22,500 sh
$322.9K
Filed 03/04
Traded 03/02
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$1.1M
75,000 sh
$1.1M
Filed 01/22
Traded 01/20
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$146K
14,587 sh
$146K
Filed 25/12/03
Traded 25/12/01
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$146.5K
14,587 sh
$146.5K
Filed 25/11/26
Traded 25/11/24
Bradley L. CampbellPresident and CEO
Sell10b5-1 planAmicus Therapeutics
Sell10b5-1 plan
Amicus Therapeutics
FOLD
$4,000
400 sh
$4,000
Filed 25/02/21
Traded 25/02/19